Table 2.
Total, n (%) | SOC arm, n (%) | Choice arm, n (%) | Mantel Haenszel OR (95% CI) adjusting for strata | Mantel Haenszel p-value | |
---|---|---|---|---|---|
Total as randomized | 305 (100%) | 155 (50.8%) | 150 (49.2%) | NA | NA |
Total per protocol | 305 (100%) | 156 (51.1%) | 149 (48.9%) | NA | NA |
Tested in clinic (intent-to-treat analysis) | |||||
Yes | 233 (76.4%) | 113 (72.9%) | 120 (80.0%) | 1.5 (0.9–2.7) | 0.189 |
No | 72 (23.5%) | 42 (27.1%) | 30 (20.0%) | NA | NA |
Tested in clinic (per protocol analysis)a | |||||
Yes | 233 (76.4%) | 114 (73.1%) | 119 (79.9%) | 1.5 (0.9–2.7) | 0.196 |
No | 72 (23.6%) | 42 (26.9%) | 30 (20.1%) | NA | NA |
Tested either in clinic or took test kit for home use (intent-to-treat analysis) | |||||
Yes | 244 (80.0%) | 113 (72.9%) | 131 (87.3%) | 2.8 (1.5–5.4) | 0.002 |
No | 61 (20.0%) | 42 (27.1%) | 19 (12.7%) | ||
Tested either in clinic or took test kit for home use (per protocol analysis)a | |||||
Yes | 244 (80.0%) | 114 (73.1%) | 130 (87.2%) | 2.8 (1.5–5.4) | 0.002 |
No | 61 (20.0%) | 42 (26.9%) | 19 (12.8%) | NA | NA |
One participant in the choice arm was only offered the SOC HIV test.